Efficacy and Safety Study of LAS41007 in the Treatment of Actinic Keratosis
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine the efficacy, safety and tolerability of either a once
or twice daily topical application of LAS41007 compared to a twice daily application of
LAS106521 in the treatment of actinic keratosis.